Literature DB >> 7605869

Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes--evidence for polygenicity in man. Danish Study Group of Diabetes in Childhood.

F Pociot1, K S Rønningen, R Bergholdt, T Lorenzen, J Johannesen, K Ye, C A Dinarello, J Nerup.   

Abstract

Fifty-five Danish families with two offspring concordant for type 1 diabetes--identified through a nationwide population-based survey, and 57 "true sporadic" cases--matched with familial cases for age at onset, but with no IDDM-affected first-degree relatives and long disease duration, and 110 control subjects were typed for putative genetic susceptibility markers for type 1 diabetes identified from a pathogenetic model. The markers included MHC class I, II and III loci, the manganese superoxide dismutase (MnSOD) locus (chr. 6q), interleukin-1 beta (IL1B), the IL-1 receptor antagonist (IL1RN), and the IL-1 type 1 receptor (IL1RI) loci (each chr. 2q). No significant differences between familial and sporadic cases were found within the MHC region (including the following loci: HLA-DQ, -DR, heat shock protein (HSP) 70, tumour necrosis factor (TNF), HLA-B and -A). In both groups of patients 11% were negative for both DQA1*0301-DQB1*0302 and DQA1*0501-DQB1*0201 genotypes, and 7% of the type 1 diabetics had genotypes unable to encode a susceptibility DQ alpha beta heterodimer. Disease association was found for the IL1RN (p = 0.04) and for the IL1RI (p = 0.03). When comparing controls and only familial cases with type 1 diabetes for the IL1RN polymorphism a difference was observed (p = 0.003). For the IL1B RFLP a trend for difference was observed between familial cases and control subjects (p = 0.046), whereas no differences between sporadic cases and control subjects could be demonstrated neither at the IL1B nor at the IL1RN loci. A difference in the MnSOD pattern was observed between sporadic cases and controls (p = 0.04).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7605869     DOI: 10.3109/08916939408995692

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  11 in total

1.  Genetic polymorphism of interleukin-1beta is associated with risk of type 1 diabetes mellitus in children.

Authors:  Dóra Krikovsky; Barna Vásárhelyi; András Treszl; Anna Körner; Attila Tordai; Tivadar Tulassay; László Madácsy
Journal:  Eur J Pediatr       Date:  2002-09       Impact factor: 3.183

2.  Novel analytical methods applied to type 1 diabetes genome-scan data.

Authors:  Flemming Pociot; Allan E Karlsen; Claus B Pedersen; Mogens Aalund; Jørn Nerup
Journal:  Am J Hum Genet       Date:  2004-03-11       Impact factor: 11.025

Review 3.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

4.  Linkage and association of the HLA gene complex with IDDM in 81 Danish families: strong linkage between DR beta 1Lys71+ and IDDM.

Authors:  M Zamani; F Pociot; M Spaepen; P Raeymaekers; J Nerup; J J Cassiman
Journal:  J Med Genet       Date:  1996-11       Impact factor: 6.318

5.  HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group.

Authors:  R Veijola; H Reijonen; P Vähäsalo; E Sabbah; P Kulmala; J Ilonen; H K Akerblom; M Knip
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

6.  Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.

Authors:  R M Lebovitz; H Zhang; H Vogel; J Cartwright; L Dionne; N Lu; S Huang; M M Matzuk
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

7.  Influence of proinflammatory cytokine gene polymorphism on childhood obesity.

Authors:  K Popko; E Górska; B Pyrzak; A Telmaszczyk-Emmel; A Wisniewska; A Majcher; M Wasik; U Demkow
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

Review 8.  The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1.

Authors:  Jay M Sosenko; Jay S Skyler; Kevan C Herold; Jerry P Palmer
Journal:  Diabetes       Date:  2012-06       Impact factor: 9.461

9.  Extended family history of type 1 diabetes and phenotype and genotype of newly diagnosed children.

Authors:  Anna Parkkola; Taina Härkönen; Samppa J Ryhänen; Jorma Ilonen; Mikael Knip
Journal:  Diabetes Care       Date:  2012-10-01       Impact factor: 19.112

10.  The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients.

Authors:  Jay M Sosenko; Jay S Skyler; Jerry P Palmer; Jeffrey P Krischer; Liping Yu; Jeffrey Mahon; Craig A Beam; David C Boulware; Lisa Rafkin; Desmond Schatz; George Eisenbarth
Journal:  Diabetes Care       Date:  2013-07-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.